Report cover image

Global End Stage Renal Disease Treatment Market Report, History and Forecast 2016-2027

Publisher QYResearch Group
Published Mar 01, 2022
Length 134 Pages
SKU # QYR17019863

Description

Global End Stage Renal Disease Treatment Market Report, History and Forecast 2016-2027

Summary

Market Analysis and Insights: Global End Stage Renal Disease Treatment Market
The research report studies the End Stage Renal Disease Treatment market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Due to the COVID-19 pandemic, the global End Stage Renal Disease Treatment market size was value at US$ 52,230.17 million in 2021 and is forecast to be a readjusted size of US$ 76,138.00 million by 2028 with a CAGR of 5.46% during the forecast period 2022-2028.
Global End Stage Renal Disease Treatment Scope and Segment
The global End Stage Renal Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global End Stage Renal Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

By Company
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical

Segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation

Segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Mexico
Brazil

Middle East & Africa
Egypt
Saudi Arabia
UAE

Table of Contents

134 Pages
1 MARKET OVERVIEW OF END STAGE RENAL DISEASE TREATMENT
1.1 END STAGE RENAL DISEASE TREATMENT MARKET OVERVIEW
1.1.1 END STAGE RENAL DISEASE TREATMENT PRODUCT SCOPE
1.1.2 END STAGE RENAL DISEASE TREATMENT MARKET STATUS AND OUTLOOK
1.2 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE OVERVIEW BY REGION 2017 VS 2021 VS 2028
1.3 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY REGION (2017-2028)
1.4 GLOBAL END STAGE RENAL DISEASE TREATMENT HISTORIC MARKET SIZE BY REGION (2017-2022)
1.5 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE FORECAST BY REGION (2023-2028)
1.6 KEY REGIONS END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
1.6.1 NORTH AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
1.6.2 EUROPE END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
1.6.3 ASIA-PACIFIC END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
1.6.4 LATIN AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
1.6.5 MIDDLE EAST & AFRICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE (2017-2028)
2 END STAGE RENAL DISEASE TREATMENT MARKET OVERVIEW BY TYPE
2.1 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY TYPE: 2017 VS 2021 VS 2028
2.2 GLOBAL END STAGE RENAL DISEASE TREATMENT HISTORIC MARKET SIZE BY TYPE (2017-2022)
2.3 GLOBAL END STAGE RENAL DISEASE TREATMENT FORECASTED MARKET SIZE BY TYPE (2023-2028)
2.4 HEMODIALYSIS
2.5 PERITONEAL DIALYSIS
2.6 KIDNEY TRANSPLANTATION
3 END STAGE RENAL DISEASE TREATMENT MARKET OVERVIEW BY APPLICATION
3.1 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY APPLICATION: 2017 VS 2021 VS 2028
3.2 GLOBAL END STAGE RENAL DISEASE TREATMENT HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
3.3 GLOBAL END STAGE RENAL DISEASE TREATMENT FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
3.4 HOSPITALS
3.5 KIDNEY DIALYSIS CENTERS
3.6 AT HOME
3.7 OTHERS
4 END STAGE RENAL DISEASE TREATMENT COMPETITION ANALYSIS BY PLAYERS
4.1 GLOBAL END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY PLAYERS (2017-2022)
4.2 GLOBAL TOP PLAYERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN END STAGE RENAL DISEASE TREATMENT AS OF 2021)
4.3 DATE OF KEY PLAYERS ENTER INTO END STAGE RENAL DISEASE TREATMENT MARKET
4.4 GLOBAL TOP PLAYERS END STAGE RENAL DISEASE TREATMENT HEADQUARTERS AND AREA SERVED
4.5 KEY PLAYERS END STAGE RENAL DISEASE TREATMENT PRODUCT SOLUTION AND SERVICE
4.6 COMPETITIVE STATUS
4.6.1 END STAGE RENAL DISEASE TREATMENT MARKET CONCENTRATION RATE
4.6.2 MERGERS & ACQUISITIONS, EXPANSION PLANS
5 COMPANY (TOP PLAYERS) PROFILES AND KEY DATA
5.1 FRESENIUS
5.1.1 FRESENIUS PROFILE
5.1.2 FRESENIUS MAIN BUSINESS
5.1.3 FRESENIUS END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.1.4 FRESENIUS END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.1.5 FRESENIUS RECENT DEVELOPMENTS
5.2 DAVITA
5.2.1 DAVITA PROFILE
5.2.2 DAVITA MAIN BUSINESS
5.2.3 DAVITA END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.2.4 DAVITA END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.2.5 DAVITA RECENT DEVELOPMENTS
5.3 BAXTER
5.3.1 BAXTER PROFILE
5.3.2 BAXTER MAIN BUSINESS
5.3.3 BAXTER END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.3.4 BAXTER END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.3.5 BAXTER RECENT DEVELOPMENTS
5.4 NIPRO
5.4.1 NIPRO PROFILE
5.4.2 NIPRO MAIN BUSINESS
5.4.3 NIPRO END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.4.4 NIPRO END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.4.5 NIPRO RECENT DEVELOPMENTS
5.5 B. BRAUN
5.5.1 B. BRAUN PROFILE
5.5.2 B. BRAUN MAIN BUSINESS
5.5.3 B. BRAUN END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.5.4 B. BRAUN END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.5.5 B. BRAUN RECENT DEVELOPMENTS
5.6 ASAHI KASEI
5.6.1 ASAHI KASEI PROFILE
5.6.2 ASAHI KASEI MAIN BUSINESS
5.6.3 ASAHI KASEI END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.6.4 ASAHI KASEI END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.6.5 ASAHI KASEI RECENT DEVELOPMENTS
5.7 NIKKISO
5.7.1 NIKKISO PROFILE
5.7.2 NIKKISO MAIN BUSINESS
5.7.3 NIKKISO END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.7.4 NIKKISO END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.7.5 NIKKISO RECENT DEVELOPMENTS
5.8 WEGO
5.8.1 WEGO PROFILE
5.8.2 WEGO MAIN BUSINESS
5.8.3 WEGO END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.8.4 WEGO END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.8.5 WEGO RECENT DEVELOPMENTS
5.9 NEWSOL
5.9.1 NEWSOL PROFILE
5.9.2 NEWSOL MAIN BUSINESS
5.9.3 NEWSOL END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.9.4 NEWSOL END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.9.5 NEWSOL RECENT DEVELOPMENTS
5.10 MAYO CLINIC
5.10.1 MAYO CLINIC PROFILE
5.10.2 MEDIONICS MAIN BUSINESS
5.10.3 MEDIONICS END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.10.4 MEDIONICS END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.10.5 MEDIONICS RECENT DEVELOPMENTS
5.11 GUANGDONG BIOLIGHT
5.11.1 GUANGDONG BIOLIGHT PROFILE
5.11.2 GUANGDONG BIOLIGHT MAIN BUSINESS
5.11.3 GUANGDONG BIOLIGHT END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.11.4 GUANGDONG BIOLIGHT END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.11.5 GUANGDONG BIOLIGHT RECENT DEVELOPMENTS
5.12 MEDTRONIC
5.12.1 MEDTRONIC PROFILE
5.12.2 MEDTRONIC MAIN BUSINESS
5.12.3 MEDTRONIC END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.12.4 MEDTRONIC END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.12.5 MEDTRONIC RECENT DEVELOPMENTS
5.13 SANXIN MEDTEC
5.13.1 SANXIN MEDTEC PROFILE
5.13.2 SANXIN MEDTEC MAIN BUSINESS
5.13.3 SANXIN MEDTEC END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.13.4 SANXIN MEDTEC END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.13.5 SANXIN MEDTEC RECENT DEVELOPMENTS
5.14 JAFRON BIOMEDICAL
5.14.1 JAFRON BIOMEDICAL PROFILE
5.14.2 JAFRON BIOMEDICAL MAIN BUSINESS
5.14.3 JAFRON BIOMEDICAL END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.14.4 JAFRON BIOMEDICAL END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.14.5 JAFRON BIOMEDICAL RECENT DEVELOPMENTS
5.15 SWS HEMODIALYSIS CARE
5.15.1 SWS HEMODIALYSIS CARE PROFILE
5.15.2 SWS HEMODIALYSIS CARE MAIN BUSINESS
5.15.3 SWS HEMODIALYSIS CARE END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.15.4 SWS HEMODIALYSIS CARE END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.15.5 SWS HEMODIALYSIS CARE RECENT DEVELOPMENTS
5.16 TIANYI MEDICAL
5.16.1 TIANYI MEDICAL PROFILE
5.16.2 TIANYI MEDICAL MAIN BUSINESS
5.16.3 TIANYI MEDICAL END STAGE RENAL DISEASE TREATMENT PRODUCTS, SERVICES AND SOLUTIONS
5.16.4 TIANYI MEDICAL END STAGE RENAL DISEASE TREATMENT REVENUE (US$ MILLION) & (2017-2022)
5.16.5 TIANYI MEDICAL RECENT DEVELOPMENTS
6 NORTH AMERICA
6.1 NORTH AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY (2017-2028)
6.2 UNITED STATES
6.3 CANADA
7 EUROPE
7.1 EUROPE END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY (2017-2028)
7.2 GERMANY
7.3 FRANCE
7.4 U.K.
7.5 ITALY
7.6 RUSSIA
8 ASIA-PACIFIC
8.1 ASIA-PACIFIC END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY REGION (2017-2028)
8.2 CHINA
8.3 JAPAN
8.4 SOUTH KOREA
8.5 SOUTHEAST ASIA
8.6 INDIA
8.7 AUSTRALIA
9 LATIN AMERICA
9.1 LATIN AMERICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY (2017-2028)
9.2 MEXICO
9.3 BRAZIL
10 MIDDLE EAST & AFRICA
10.1 MIDDLE EAST & AFRICA END STAGE RENAL DISEASE TREATMENT MARKET SIZE BY COUNTRY
10.2 SAUDI ARABIA
10.3 UAE
10.4 EGYPT
10.5 SOUTH AFRICA
11 GLOBAL ESRD PATIENTS POPULATION BY MAJOR REGIONS IN 2022
12 END STAGE RENAL DISEASE TREATMENT MARKET DYNAMICS
12.1 END STAGE RENAL DISEASE TREATMENT INDUSTRY TRENDS
12.2 END STAGE RENAL DISEASE TREATMENT MARKET DRIVERS
12.3 END STAGE RENAL DISEASE TREATMENT MARKET CHALLENGES
12.4 END STAGE RENAL DISEASE TREATMENT MARKET RESTRAINTS
13 RESEARCH FINDING/CONCLUSION
14 METHODOLOGY AND DATA SOURCE
14.1 METHODOLOGY/RESEARCH APPROACH
14.1.1 RESEARCH PROGRAMS/DESIGN
14.1.2 MARKET SIZE ESTIMATION
14.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION
14.2 DATA SOURCE
14.2.1 SECONDARY SOURCES
14.2.2 PRIMARY SOURCES
14.3 AUTHOR LIST
14.4 DISCLAIMER
List of Tables
Table 1. Global Market End Stage Renal Disease Treatment Market Size (US$ Million) Comparison by Region: 2017 VS 2021 VS 2028
Table 2. Global End Stage Renal Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 3. Global End Stage Renal Disease Treatment Market Size Share by Region (2017-2022)
Table 4. Global End Stage Renal Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 5. Global End Stage Renal Disease Treatment Forecasted Market Size Share by Region (2023-2028)
Table 6. Global End Stage Renal Disease Treatment Market Size (US$ Million) by Type: 2017 VS 2021 VS 2028
Table 7. Global End Stage Renal Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 8. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2017-2022)
Table 9. Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 10. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2023-2028)
Table 11. Global End Stage Renal Disease Treatment Market Size by Application: (US$ Million) 2017 VS 2021 VS 2028
Table 12. Global End Stage Renal Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 13. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2017-2022)
Table 14. Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 15. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2023-2028)
Table 16. Global End Stage Renal Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global End Stage Renal Disease Treatment Revenue Market Share by Players (2017-2022)
Table 18. Global Top Players Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease Treatment as of 2021)
Table 19. Date of Key Players Enter into End Stage Renal Disease Treatment Market
Table 20. Global End Stage Renal Disease Treatment Top Players Headquarters and Area Served
Table 21. End Stage Renal Disease Treatment Product Solution and Service
Table 22. Global End Stage Renal Disease Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Fresenius Basic Information List
Table 25. Fresenius Description and Business Overview
Table 26. Fresenius End Stage Renal Disease Treatment Products, Services and Solutions32

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us